enVVeno Medical Corporation
NVNO
$2.48
-$0.11-4.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.19M | 3.31M | 2.63M | 2.45M | 3.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.70M | 6.17M | 5.45M | 5.50M | 6.28M |
| Operating Income | -6.70M | -6.17M | -5.45M | -5.50M | -6.28M |
| Income Before Tax | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M |
| EBIT | -6.70M | -6.17M | -5.45M | -5.50M | -6.28M |
| EBITDA | -6.66M | -6.13M | -5.40M | -5.45M | -6.22M |
| EPS Basic | -0.31 | -0.35 | -0.37 | -0.37 | -0.36 |
| Normalized Basic EPS | -0.20 | -0.24 | -0.25 | -0.26 | -0.25 |
| EPS Diluted | -0.31 | -0.35 | -0.37 | -0.37 | -0.36 |
| Normalized Diluted EPS | -0.20 | -0.24 | -0.25 | -0.26 | -0.25 |
| Average Basic Shares Outstanding | 20.38M | 16.07M | 13.33M | 13.33M | 15.51M |
| Average Diluted Shares Outstanding | 20.38M | 16.07M | 13.33M | 13.33M | 15.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
